Taiko Pharmaceutical News

Taiko Pharmaceutical: Confirmation

Futu NewsMay 10 02:37 ET · Announcements

Taiko Pharmaceutical: Quarterly Report - 79th Term 1st Quarter (2024/01/01 - 2024/03/31)

Futu NewsMay 10 02:35 ET · Announcements

Taiko Pharmaceutical Sees FY Net Y550.00M

Taiko Pharmaceutical Co. Ltd. also released the following forecasts: GROUP Year Ending Dec 2024 Revenue Y6.80 bln Operating Profit Y410.00 mln Pre

Dow JonesMay 10 02:32 ET

Taiko Pharmaceutical: Summary of Financial Results for the 1st Quarter of the Fiscal Year Ending 2024/12 [Japanese GAAP] (Consolidated)

Futu NewsMay 10 02:30 ET · Announcements

Taiko Pharmaceutical: Consolidated Financial Results Report for the 1st Quarter of the Fiscal Year Ending 2024/12 (FY2024)

Futu NewsMay 10 02:30 ET · Announcements

List of Unrivaled Stocks (Part 2) [Ichimoku Equilibrium Chart/Kumoku Stock List]

○List of Unbroken Stocks Market Code Stock Name Closing Price Advance Span A Advance Span B Tokyo Stock Exchange Prime ＜2229＞ Calbee 3147 3386 3202 ＜2301＞ Academic Information 1790 1795 1795.5 ＜2445＞ Takamiya 539 572 540.5 ＜3393＞ 　

Fisco JapanMay 9 18:42 ET

Daiwa House, Meiji HD, Shiseido, Sumitomo Electric (10th) (1301-5998)

*The above calendar is just a schedule and is subject to change due to company circumstances. ---------------------------------------5/10 (Fri) ＜1301＞Kyokuyo ＜1379＞Hokuto ＜1414＞Show Bond ＜1420＞Sanyo H＜1429＞Japan Aqua ＜1431＞Ribwork＜1435＞Robot Home ＜1438＞Gifu Landscaping＜1

Fisco JapanMay 9 17:30 ET

Convertible Stock List (Part 1) [Parabolic Signal Convertible Stock List]

○ List of buy conversion stocks market code stock name closing price SAR Tokyo Stock Exchange Prime ＜2301＞ academic information 1839 1682 ＜2326＞ Digiarts 4425 4040 ＜2379＞ dip 2770 2576 ＜2440＞ GURUNAVI 335 295 ＜2461＞ fan reviews 　 　 　 　

Fisco JapanMay 7 19:36 ET

List of Unrivaled Stocks (Part 1) [Ichimoku Equilibrium Chart/Kumoku Stock List]

○Cloud Top Stock List Market Code Stock Name Closing Price Advance Span A Prior Span B Tokyo Stock Exchange Prime ＜3031＞ Raccoon HD 653 621.75 651 ＜7380＞ 16 FG 4560 4546.25 4280 ＜7581＞ Saizeriya 5280 4937.5 5212.5 ＜9692＞ CEC 1717 170

Fisco JapanApr 21 18:46 ET

Convertible Stock List (Part 3) [Parabolic Signal Convertible Stock List]

○ List of sales conversion stocks market code stock name closing price SAR Tokyo Stock Exchange Prime ＜1873＞ Japan House HD 337 361 ＜2882＞ Eat and 1983 2046 ＜3288＞ Open H 4919 5054 ＜3387＞ Kriles HD 1045 1070 ＜3501＞ Suminoe Textile 　 　 　 　　

Fisco JapanApr 14 18:57 ET

Taiko Pharmaceutical Raises FY Net View to Y550.00M

GROUP New Forecast Prior For Year To Dec 2024 Forecast Revenue Y6.80 bln Y6.80 bln Operating Profit Y410.00 mln

Dow JonesMar 7 01:30 ET

Taiko Pharmaceutical Sees FY Net Y350.00M

Taiko Pharmaceutical Co. Ltd. also released the following forecasts: GROUP Year Ending Dec 2024 Revenue Y6.80 bln Operating Profit Y410.00 mln Pre

Dow JonesFeb 9 01:30 ET

Taiko Pharmaceutical 9-Mos Loss Y562.00M Vs Loss Y3.18B

Taiko Pharmaceutical Co. Ltd. (4574.TO) Japan Nine Months Ended September 30 GROUP 2023 2022 Revenue Y4.42 bln Y3.39 bln Operating Profit

Dow JonesNov 10, 2023 01:31 ET

Kingworld Medicines Subsidiary Buys Shares in Taiko Pharmaceutical

Kingworld Medicines Group (HKG:1110) subsidiary Kingworld Medicines Health Management purchased an additional 1,007,500 shares in Japan-based Taiko Pharmaceutical (TYO:4574) at 338.58 yen per share, a

MT NewswiresAug 15, 2023 23:10 ET

Jinhuo Pharmaceutical Group (01110.HK): Further subscription for shares in Taiko Pharmaceutical

On August 16, 2023, Goldwell Pharmaceutical Group (01110.HK) issued an announcement. On August 15, 2023, Jinhuo Pharmaceutical, a wholly-owned subsidiary of the company, placed an order with the distribution agent. Based on this, Jinhuo Pharmaceutical agreed to subscribe for an additional 1.075 million Taiko shares at a cost of 338.58 yen (equivalent to about HK$18.35) per share of Taiko Shares (accounting for about 2.08% of Taiko Pharmaceutical's issued share capital as of the date of this announcement, excluding Taiko Pharmaceutical After completion, according to the subscription details

Gelonghui FinanceAug 15, 2023 18:25 ET

Taiko Pharmaceutical 1H Loss Y514.00M Vs Loss Y2.80B

Taiko Pharmaceutical Co. Ltd. (4574.TO) Japan 1st Half Ended June 30 GROUP 2023 2022 Revenue Y2.49 bln Y1.86 bln Operating Profit (Y396.

Dow JonesAug 10, 2023 02:31 ET

Taiko Pharmaceutical 1Q Loss Y243.00M Vs Loss Y1.75B

Taiko Pharmaceutical Co. Ltd. (4574.TO) Japan 1st Quarter Ended March 31 GROUP 2023 2022 Revenue Y1.17 bln Y621.00 mln Operating Profi

Dow JonesMay 12, 2023 02:33 ET

Kingworld Medicines to Invest 832 Million Yen in Taiko Pharmaceutical

04:50 AM EDT, 04/25/2023 (MT Newswires) -- Kingworld Medicines Group (HKG:1110) is subscribing to 2.2 million shares in Taiko Pharmaceutical (TYO:4574) for 832.1 million yen, according to a Monday fil

MT NewswiresApr 25, 2023 04:57 ET

Taiko Pharmaceutical to Pay 607 Million Yen Penalty; Shares Down 3%

06:42 AM EDT, 04/12/2023 (MT Newswires) -- Taiko Pharmaceutical (TYO:4574) was fined 607.4 million yen by Japan's Consumer Affairs Agency on Tuesday for baselessly claiming that its Cleverin sanitizer

MT NewswiresApr 12, 2023 06:48 ET

Taiko Pharmaceutical Sees FY Net Y50.00M

Taiko Pharmaceutical Co. Ltd. also released the following forecasts: GROUP Year Ending Dec 2023 Revenue Y7.90 bln Operating Profit Y532.00 ml

Dow JonesFeb 10, 2023 01:38 ET